File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1016/j.cellsig.2023.110748
- Scopus: eid_2-s2.0-85161657107
- WOS: WOS:001027069700001
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1
Title | MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1 |
---|---|
Authors | |
Keywords | BTBD1 miR-200b-5p PI3K/AKT Salivary adenoid cystic carcinoma (SACC) Tumor progression |
Issue Date | 1-Sep-2023 |
Publisher | Elsevier |
Citation | Cellular Signalling, 2023, v. 109 How to Cite? |
Abstract | Salivary adenoid cystic carcinoma (SACC) is a rare malignant tumor of the salivary gland. Studies have suggested that miRNA may play a crucial role in the invasion and metastasis of SACC. This study aimed to investigate the role of miR-200b-5p in SACC progression. Reverse transcription-quantitative PCR and western blot assay were used to detect the expression levels of miR-200b-5p and BTBD1. The biological functions of miR-200b-5p were evaluated via wound-healing assays, transwell assays, and xenograft nude mice model. The interaction between miR-200b-5p and BTBD1 was assessed using luciferase assay. Results showed that miR-200b-5p was downregulated in the SACC tissues while BTBD1 was upregulated. miR-200b-5p overexpression suppressed SACC cell proliferation, migration, invasion, and epithelial-mesenchymal transition (EMT). Bioinformatics prediction and luciferase reporter assay revealed that miR-200b-5p could directly bind to BTBD1. Besides, miR-200b-5p overexpression could rescue the tumor-promoting effect of BTBD1. miR-200b-5p inhibited tumor progression by modulating EMT-related proteins, targeting BTBD1 and inhibiting PI3K/AKT signaling pathway. Overall, our findings indicate that miR-200b-5p can suppress SACC proliferation, migration, invasion, and EMT by regulating BTBD1 and PI3K/AKT axis, providing a promising therapeutic target for SACC treatment. |
Persistent Identifier | http://hdl.handle.net/10722/331509 |
ISSN | 2021 Impact Factor: 4.850 2020 SCImago Journal Rankings: 1.435 |
ISI Accession Number ID |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Tang, Yuting | - |
dc.contributor.author | Zhu, Qinghai | - |
dc.contributor.author | Yang, Li | - |
dc.contributor.author | Meng, Ying | - |
dc.contributor.author | Zhang, Gao | - |
dc.contributor.author | Zhou, Tian | - |
dc.contributor.author | Wang, Chenxing | - |
dc.contributor.author | Song, Xiaomeng | - |
dc.contributor.author | Su, Yu-Xiong | - |
dc.contributor.author | Ye, Jinhai | - |
dc.date.accessioned | 2023-09-21T06:56:29Z | - |
dc.date.available | 2023-09-21T06:56:29Z | - |
dc.date.issued | 2023-09-01 | - |
dc.identifier.citation | Cellular Signalling, 2023, v. 109 | - |
dc.identifier.issn | 0898-6568 | - |
dc.identifier.uri | http://hdl.handle.net/10722/331509 | - |
dc.description.abstract | <p>Salivary adenoid cystic carcinoma (SACC) is a rare malignant tumor of the salivary gland. Studies have suggested that miRNA may play a crucial role in the invasion and metastasis of SACC. This study aimed to investigate the role of miR-200b-5p in SACC progression. Reverse transcription-quantitative PCR and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/western-blot" title="Learn more about western blot from ScienceDirect's AI-generated Topic Pages">western blot</a> assay were used to detect the expression levels of miR-200b-5p and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/btb-poz-domain" title="Learn more about BTBD1 from ScienceDirect's AI-generated Topic Pages">BTBD1</a>. The biological functions of miR-200b-5p were evaluated via wound-healing assays, transwell assays, and xenograft <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/nude-mouse" title="Learn more about nude mice from ScienceDirect's AI-generated Topic Pages">nude mice</a> model. The interaction between miR-200b-5p and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/btb-poz-domain" title="Learn more about BTBD1 from ScienceDirect's AI-generated Topic Pages">BTBD1</a> was assessed using <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/luciferase" title="Learn more about luciferase from ScienceDirect's AI-generated Topic Pages">luciferase</a> assay. Results showed that miR-200b-5p was downregulated in the SACC tissues while BTBD1 was upregulated. miR-200b-5p overexpression suppressed SACC <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/cell-proliferation" title="Learn more about cell proliferation from ScienceDirect's AI-generated Topic Pages">cell proliferation</a>, migration, invasion, and epithelial-mesenchymal transition (EMT). Bioinformatics prediction and <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/luciferase" title="Learn more about luciferase from ScienceDirect's AI-generated Topic Pages">luciferase</a> reporter assay revealed that miR-200b-5p could directly bind to BTBD1. Besides, miR-200b-5p overexpression could rescue the tumor-promoting effect of BTBD1. miR-200b-5p inhibited tumor progression by modulating EMT-related proteins, targeting BTBD1 and inhibiting PI3K/AKT <a href="https://www.sciencedirect.com/topics/biochemistry-genetics-and-molecular-biology/signal-transduction" title="Learn more about signaling pathway from ScienceDirect's AI-generated Topic Pages">signaling pathway</a>. Overall, our findings indicate that miR-200b-5p can suppress SACC proliferation, migration, invasion, and EMT by regulating BTBD1 and PI3K/AKT axis, providing a promising therapeutic target for SACC treatment.</p> | - |
dc.language | eng | - |
dc.publisher | Elsevier | - |
dc.relation.ispartof | Cellular Signalling | - |
dc.rights | This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License. | - |
dc.subject | BTBD1 | - |
dc.subject | miR-200b-5p | - |
dc.subject | PI3K/AKT | - |
dc.subject | Salivary adenoid cystic carcinoma (SACC) | - |
dc.subject | Tumor progression | - |
dc.title | MiR-200b-5p inhibits tumor progression in salivary adenoid cystic carcinoma via targeting BTBD1 | - |
dc.type | Article | - |
dc.identifier.doi | 10.1016/j.cellsig.2023.110748 | - |
dc.identifier.scopus | eid_2-s2.0-85161657107 | - |
dc.identifier.volume | 109 | - |
dc.identifier.isi | WOS:001027069700001 | - |
dc.identifier.issnl | 0898-6568 | - |